Home › NDC Lookup › RxCUI directory › RxCUI 387013

Nebivolol 5 MG Oral Tablet — RxCUI 387013

RxNorm drug concept · Semantic clinical drug
RxCUI 387013 Semantic clinical drug · SCD ● Current RxNorm concept 85 FDA products 219 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI387013
Official nameNebivolol 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnebivolol (as nebivolol hydrochloride) 5 MG Oral Tablet
FDA products mapped85
Package NDCs mapped219
Reported Medicaid activity (SDUD)91,607 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nebivolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nebivolol is used to treat high blood pressure — that's its approved use. By bringing your blood pressure down, it helps lower your risk of serious problems like stroke and heart a...
  • Please don't stop it suddenly without talking to your doctor first. If you have any underlying heart disease, stopping abruptly can trigger chest pain, a heart attack, or dangerous...
  • Can I stop taking nebivolol if I feel fine or don't like the side effects?
  • No — nebivolol can be taken with or without food. It doesn't change how the drug is absorbed or how well it works. The most important thing is to take it at roughly the same time e...
📖 Read our full Nebivolol guide →

🕸️ Concept Web — How Nebivolol 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nebivolol 5 MG Oral Tablet RxCUI 387013

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nebivolol 31555
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bystolic 751613
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nebivolol Oral Tablet 393308
    • Nebivolol Oral Product 1158401
    • Nebivolol Pill 1158402
    • Nebivolol Oral Tablet [Bystolic] 751615
    • Bystolic Oral Product 1169416
    • Bystolic Pill 1169417
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nebivolol 5 MG SCDC · 393307
  • Nebivolol Oral Tablet SCDF · 393308
  • Nebivolol Oral Product SCDG · 1158401
  • Nebivolol Pill SCDG · 1158402

Brand-Name Concepts

  • Nebivolol 5 MG Oral Tablet [Bystolic] SBD · 751623
  • Nebivolol 5 MG [Bystolic] SBDC · 751622
  • Nebivolol Oral Tablet [Bystolic] SBDF · 751615
  • Bystolic Oral Product SBDG · 1169416
  • Bystolic Pill SBDG · 1169417
  • Bystolic BN · 751613

📦 FDA Products & Package NDCs

85 products · 219 package NDCs
219 package NDCs map to RxCUI 387013 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59651-0140-90 90 TABLET in 1 BOTTLE (59651-140-90) Nebivolol Aurobindo Pharma Limited 2021-12-17
60687-0641-21 30 BLISTER PACK in 1 CARTON (60687-641-21) / 1 TABLET in 1... Nebivolol American Health Packaging 2022-09-07
60687-0652-21 30 BLISTER PACK in 1 CARTON (60687-652-21) / 1 TABLET in 1... Nebivolol American Health Packaging 2022-09-07
62559-0275-30 30 TABLET in 1 BOTTLE (62559-275-30) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0275-83 2300 TABLET in 1 BOTTLE (62559-275-83) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0276-30 30 TABLET in 1 BOTTLE (62559-276-30) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0276-71 1100 TABLET in 1 BOTTLE (62559-276-71) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0276-90 90 TABLET in 1 BOTTLE (62559-276-90) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0277-05 500 TABLET in 1 BOTTLE (62559-277-05) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0277-30 30 TABLET in 1 BOTTLE (62559-277-30) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0277-90 90 TABLET in 1 BOTTLE (62559-277-90) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0278-05 500 TABLET in 1 BOTTLE (62559-278-05) Nebivolol ANI Pharmaceuticals, Inc. 2021-11-15
62559-0278-30 30 TABLET in 1 BOTTLE (62559-278-30) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
62559-0278-90 90 TABLET in 1 BOTTLE (62559-278-90) Nebivolol ANI Pharmaceuticals, Inc. 2021-09-17
63629-4693-01 30 TABLET in 1 BOTTLE (63629-4693-1) Nebivolol Bryant Ranch Prepack 2024-10-22
63629-9589-01 90 TABLET in 1 BOTTLE (63629-9589-1) NEBIVOLOL Bryant Ranch Prepack 2022-12-01
63629-9589-02 30 TABLET in 1 BOTTLE (63629-9589-2) NEBIVOLOL Bryant Ranch Prepack 2022-12-01
67877-0390-01 100 TABLET in 1 BOTTLE (67877-390-01) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0390-30 30 TABLET in 1 BOTTLE (67877-390-30) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0390-33 1 BLISTER PACK in 1 CARTON (67877-390-33) / 10 TABLET in 1... Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0390-90 90 TABLET in 1 BOTTLE (67877-390-90) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0391-01 100 TABLET in 1 BOTTLE (67877-391-01) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0391-30 30 TABLET in 1 BOTTLE (67877-391-30) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0391-33 1 BLISTER PACK in 1 CARTON (67877-391-33) / 10 TABLET in 1... Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0391-90 90 TABLET in 1 BOTTLE (67877-391-90) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0392-01 100 TABLET in 1 BOTTLE (67877-392-01) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0392-30 30 TABLET in 1 BOTTLE (67877-392-30) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0392-33 1 BLISTER PACK in 1 CARTON (67877-392-33) / 10 TABLET in 1... Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0392-90 90 TABLET in 1 BOTTLE (67877-392-90) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0393-01 100 TABLET in 1 BOTTLE (67877-393-01) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0393-30 30 TABLET in 1 BOTTLE (67877-393-30) Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0393-33 1 BLISTER PACK in 1 CARTON (67877-393-33) / 10 TABLET in 1... Nebivolol Ascend Laboratories, LLC 2021-09-16
67877-0393-90 90 TABLET in 1 BOTTLE (67877-393-90) Nebivolol Ascend Laboratories, LLC 2021-09-16
68462-0615-01 100 TABLET in 1 BOTTLE (68462-615-01) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0615-11 10 BLISTER PACK in 1 CARTON (68462-615-11) / 10 TABLET in 1... nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0615-30 30 TABLET in 1 BOTTLE (68462-615-30) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0616-01 100 TABLET in 1 BOTTLE (68462-616-01) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0616-11 10 BLISTER PACK in 1 CARTON (68462-616-11) / 10 TABLET in 1... nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0616-30 30 TABLET in 1 BOTTLE (68462-616-30) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0617-01 100 TABLET in 1 BOTTLE (68462-617-01) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0617-11 10 BLISTER PACK in 1 CARTON (68462-617-11) / 10 TABLET in 1... nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0617-30 30 TABLET in 1 BOTTLE (68462-617-30) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0618-01 100 TABLET in 1 BOTTLE (68462-618-01) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0618-11 10 BLISTER PACK in 1 CARTON (68462-618-11) / 10 TABLET in 1... nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
68462-0618-30 30 TABLET in 1 BOTTLE (68462-618-30) nebivolol Glenmark Pharmaceuticals Inc., USA 2017-05-25
70518-3527-00 90 TABLET in 1 BOTTLE, PLASTIC (70518-3527-0) Nebivolol REMEDYREPACK INC. 2022-09-20
70518-4032-00 90 TABLET in 1 BOTTLE, PLASTIC (70518-4032-0) NEBIVOLOL REMEDYREPACK INC. 2024-03-05
70518-4648-00 50 POUCH in 1 BOX (70518-4648-0) / 1 TABLET in 1 POUCH (705... NEBIVOLOL REMEDYREPACK INC. 2026-04-28
70756-0025-30 30 TABLET in 1 BOTTLE (70756-025-30) Nebivolol Lifestar Pharma LLC 2022-11-14
70756-0291-30 30 TABLET in 1 BOTTLE (70756-291-30) Nebivolol Lifestar Pharma LLC 2022-11-14
Observed labelers: Camber Pharmaceuticals, Inc. (19) · Ascend Laboratories, LLC (16) · Cadila Pharmaceuticals Limited (16) · Modavar Pharmaceuticals LLC (16) · Novadoz Pharmaceuticals LLC (16) · Allergan, Inc. (13) · +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.